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Letter to the Editor
Letters to the Editor will be published, if suitable, as space permits. They should not exceed 1000 words
(typed double-spaced) in length and may be subject to editing or abridgment.
Is Arterial Stiffness Related to Body Height?
To the Editor:
Experts1 consider aortic pulse wave velocity (PWV) as the
supreme index of arterial stiffness, mainly because it is an
independent predictor of cardiovascular complications.2 How-
ever, the noninvasive assessment of PWV is critically dependent
on the measurement of the travel distance of the arterial pulse
wave.3 Variability between estimates of PWV largely depends on
inconsistencies in the measured travel distance.4 Travel distance
is proportional to body height.5 This explains the inverse asso-
ciation between PWV and body height. In a recent publication in
Hypertension, Wang et al6 recognized the problem and adjusted
the hazard ratios expressing the risk of death related to a pulse
wave reflection index for body height.
The Colin VP-1000 (Omron Healthcare) is easy to operate and is
used for risk stratification, in particular in Japan and China.7 This
device measures brachial-ankle PWV (baPWV) by means of an
automated wave form analyzer. In 200 subjects (51.5% women;
mean age: 51.3 years; age range: 20 to 80 years) recruited in the
framework of the Flemish Study on Environment Genes and Health
Outcomes,8 we observed a strong inverse association between
baPWV and body height (Table). However, the VP-1000 device
computes baPWV automatically as (L1L2)/T.9 L1 is the distance
from the heart to the ankle, L2 is the distance from the heart to the
arm, and T is the time delay between the feet of the brachial and
tibial arterial waveforms. The VP-1000 computes L1 and L2 from
the height (H) of the subjects as L10.2195H2.0734 and
L20.5643H18.381.9 For this reason, we believe that the
inverse association between baPWV and body height is spurious.
Leading experts in the field recently proposed other formulas to
extrapolate travel distance from height.5 Another limitation of
baPWV is that this index mixes the characteristics of the elastic
aorta and subclavian arteries and the muscular brachial, femoral, and
tibial arteries.
In the same Flemish Study on Environment Genes and Health
Outcomes participants,8 we also measured aortic PWV from the
length of the carotid-femoral segment and the transit time of the
pulse wave. The carotid-femoral segment (cfD) was the distance
between the suprasternal notch and the site of the femoral
measurement (nfD) minus the distance between the site of the
carotid measurement and the suprasternal notch (cnD). We
measured these distances using a measuring tape. Thus, for aortic
PWV, travel distance was not extrapolated from height. In
contrast to baPWV, aortic PWV was not significantly correlated
with body height (Table). Nevertheless, cfD (r0.41), nfD
(r0.56), and cnD (r0.43)) were all closely correlated
(P0.0001) with body height, highlighting that even the best
index of arterial stiffness not only depends on the characteristics
the measured arterial segment.
We also measured the central and peripheral systolic augmen-
tation indices.8 We used a high-fidelity SPC-301 micromanom-
eter (Millar Instruments, Inc) interfaced with a laptop computer
running the SphygmoCor software, version 7.1 (AtCor Medical
Pty Ltd). Measurement of the systolic augmentation indices does
not involve travel distance. Nevertheless, in line with our
previous study of a Chinese population,10 we noticed a signifi-
cant inverse association between systolic augmentation and body
height (Table), which can be easily explained by the faster return
of the reflected wave in shorter people.
In conclusion, travel distance remains a major problem in the
standardization and interpretation of PWV as the favored1 index
of arterial stiffness. The inverse association between PWV and
height is overestimated if travel distance is extrapolated from
height. For the same height, aortic PWV reflects only arterial
stiffness, but if height is dissimilar PWV reflects both arterial
properties and the difference in stature. We suggest that PWV be
expressed standardized to height (and heart rate) and that
analyses involving PWV as the explanatory variable should be
adjusted for body height (and heart rate), as done recently by
Wang et al.6
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Table. Association of Various Indices of Arterial Stiffness
With Body Height
Characteristic All Subjects Women Men
No. of subjects 200 103 97
Brachial-ankle PWV,
cm/s per cm
5.392.00* 16.214.51† 14.882.82†
Carotid-femoral
PWV, cm/s per cm
1.101.32 2.702.36 2.102.51
Central AI, %/cm 1.260.18† 1.480.36† 1.240.37*
Peripheral AI, %/cm 1.010.15† 1.310.29† 1.050.30†
AI indicates systolic augmentation index. Values are single regression
coefficientsSE.
*P0.01 indicates significance of the regression coefficient.
†P0.0001 indicates significance of the regression coefficient.
(Hypertension. 2010;55:e24-e25.)
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